Patient Advocacy Groups – Key Support System When Planning the Launch of an Orphan Drug in Brazil
Patient advocacy groups (PAGs) for orphan diseases in Brazil (e.g., Instituto Vidas Raras, Casa Hunter) support manufacturers during all phases of launching an orphan drug.
| Blog | Healthcare & Life Sciences Customer, Product & Market Strategy